Allan H. Friedman

39.3k total citations · 8 hit papers
345 papers, 25.7k citations indexed

About

Allan H. Friedman is a scholar working on Genetics, Neurology and Epidemiology. According to data from OpenAlex, Allan H. Friedman has authored 345 papers receiving a total of 25.7k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Genetics, 102 papers in Neurology and 76 papers in Epidemiology. Recurrent topics in Allan H. Friedman's work include Glioma Diagnosis and Treatment (128 papers), Meningioma and schwannoma management (60 papers) and Brain Metastases and Treatment (40 papers). Allan H. Friedman is often cited by papers focused on Glioma Diagnosis and Treatment (128 papers), Meningioma and schwannoma management (60 papers) and Brain Metastases and Treatment (40 papers). Allan H. Friedman collaborates with scholars based in United States, Japan and Canada. Allan H. Friedman's co-authors include Henry S. Friedman, Darell D. Bigner, Roger E. McLendon, James E. Herndon, John H. Sampson, David A. Reardon, James J. Vredenburgh, Annick Desjardins, Jeremy N. Rich and Jennifer A. Quinn and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Allan H. Friedman

339 papers receiving 25.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH1andIDH2Mutations in Gliomas

2009 4.2k citations Roger E. McLendon, Henry S. Friedman et al. profile →
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

2007 1.0k citations James J. Vredenburgh, Annick Desjardins et al. Journal of Clinical Oncology profile →
Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

2007 815 citations James J. Vredenburgh, Annick Desjardins et al. Clinical Cancer Research profile →
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

2010 613 citations John H. Sampson, Amy B. Heimberger et al. Journal of Clinical Oncology profile →
Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

1999 608 citations Henry S. Friedman, Allan H. Friedman et al. Journal of Clinical Oncology profile →
Recurrent Glioblastoma Treated with Recombinant Poliovirus

2018 582 citations Annick Desjardins, James E. Herndon et al. profile →
Phase II Trial of Gefitinib in Recurrent Glioblastoma

2003 558 citations Jeremy N. Rich, David A. Reardon et al. Journal of Clinical Oncology profile →
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

2015 410 citations Duane A. Mitchell, Kristen A. Batich et al. profile →

Peers

Countries citing papers authored by Allan H. Friedman

Since Specialization

Citations

This map shows the geographic impact of Allan H. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan H. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan H. Friedman more than expected).

Fields of papers citing papers by Allan H. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan H. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan H. Friedman. The network helps show where Allan H. Friedman may publish in the future.

Co-authorship network of co-authors of Allan H. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Allan H. Friedman. A scholar is included among the top collaborators of Allan H. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan H. Friedman. Allan H. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta‐Analysis, and Network Meta‐Analysis 2024 ·Journal of the American Heart Association ·Basel Musmar, Hamza Salim, Jihad Abdelgadir, Samantha Spellicy, Nimer Adeeb, Ali Zomorodi, Allan H. Friedman, Issam A. Awad, Pascal Jabbour, David Hasan	4
2	Single‐institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice 2019 ·Health Science Reports ·Annick Desjardins, James E. Herndon, Frances McSherry, Arliene Ravelo, Eric Lipp, Patrick Healy, Katherine B. Peters, John H. Sampson, Dina Randazzo, Nicolas Sommer, Allan H. Friedman, Henry S. Friedman	11
3	Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination 2017 ·Clinical Cancer Research ·Kristen A. Batich, Elizabeth A. Reap, Gary E. Archer, Luis Sánchez-Pérez, Smita K. Nair, Robert J. Schmittling, (unknown), Weihua Xie, James E. Herndon, Patrick Healy, Roger E. McLendon, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, Gordana Vlahovic, Duane A. Mitchell, John H. Sampson	242
4	Microsurgical resection of vestibular schwannomas: complication avoidance 2016 ·Journal of Neuro-Oncology ·Shervin Rahimpour, Allan H. Friedman, Takanori Fukushima, Ali Zomorodi	14
5	Comparison of postoperative nausea between benign and malignant brain tumor patients undergoing awake craniotomy: a retrospective analysis 2013 ·Current Medical Research and Opinion ·Manzhao Ouyang, David L. McDonagh, Yi‐Ju Li, Michael L. James, Allan H. Friedman, Tong J. Gan	7
6	Cerebellopontine angle meningiomas: postoperative outcomes in a modern cohort 2013 ·Neurosurgical FOCUS ·Vijay Agarwal, Ranjith Babu, (unknown), Owoicho Adogwa, (unknown), Allan H. Friedman, Takanori Fukushima, Cory Adamson	32
7	Less invasive transjugular approach with Fallopian bridge technique for facial nerve protection and hearing preservation in surgery of glomus jugulare tumors 2013 ·Neurosurgical Review ·Yoichi Nonaka, Takanori Fukushima, Kentaro Watanabe, Allan H. Friedman, John T. McElveen, Calhoun D. Cunningham, Ali Zomorodi	12
8	A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma 2012 ·PLoS ONE ·John H. Sampson, Robert J. Schmittling, Gary E. Archer, Kendra L. Congdon, Smita K. Nair, Elizabeth A. Reap, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, James E. Herndon, April Coan, Roger E. McLendon, David A. Reardon, James J. Vredenburgh, Darell D. Bigner, Duane A. Mitchell	91
9	Exercise Behavior, Functional Capacity, and Survival in Adults With Malignant Recurrent Glioma 2011 ·Journal of Clinical Oncology ·(unknown), David A. Reardon, April Coan, James E. Herndon, Whitney Hornsby, M. West, Diane Fels, Annick Desjardins, James J. Vredenburgh, (unknown), Allan H. Friedman, Henry S. Friedman, Katherine B. Peters, Lee W. Jones	94
10	The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma 2011 ·Clinical Cancer Research ·James J. Vredenburgh, Annick Desjardins, David A. Reardon, Katherine B. Peters, James E. Herndon, Jennifer Marcello, John P. Kirkpatrick, John H. Sampson, Leighann Bailey, Stevie Threatt, Allan H. Friedman, Darell D. Bigner, Henry S. Friedman	112
11	Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma breakdown → 2010 ·Journal of Clinical Oncology ·John H. Sampson, Amy B. Heimberger, Gary E. Archer, Kenneth Aldape, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon, Duane A. Mitchell, David A. Reardon, Raymond Sawaya, Robert J. Schmittling, Weiming Shi, James J. Vredenburgh, Darell D. Bigner	613
12	An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme 2009 ·Molecular Cancer Therapeutics ·John H. Sampson, Gary E. Archer, Duane A. Mitchell, Amy B. Heimberger, James E. Herndon, Denise Lally-Goss, (unknown), (unknown), David A. Reardon, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner	221
13	Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas 2008 ·Clinical Cancer Research ·Annick Desjardins, David A. Reardon, James E. Herndon, Jennifer Marcello, Jennifer A. Quinn, Jeremy N. Rich, Sith Sathornsumetee, Sridharan Gururangan, John H. Sampson, Leighann Bailey, Darell D. Bigner, Allan H. Friedman, Henry S. Friedman, James J. Vredenburgh	130
14	INTRACEREBRAL INFUSATE DISTRIBUTION BY CONVECTION-ENHANCED DELIVERY IN HUMANS WITH MALIGNANT GLIOMAS 2007 ·Operative Neurosurgery ·John H. Sampson, Martin Brady, Neil A. Petry, David Croteau, Allan H. Friedman, Henry S. Friedman, Terence Z. Wong, Darell D. Bigner, Ira Pastan, Raj K. Puri, Christoph Pedain	112
15	Clinical Experience with α-Particle–Emitting ²¹¹At: Treatment of Recurrent Brain Tumor Patients with ²¹¹At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6 2007 ·Journal of Nuclear Medicine ·Michael R. Zalutsky, David A. Reardon, Gamal Akabani, R. Edward Coleman, Allan H. Friedman, Henry S. Friedman, Roger E. McLendon, Terence Z. Wong, Darell D. Bigner	300
16	Cranioplasty after trephination using a novel biodegradable burr hole cover : Technical case report. Commentary 2006 ·Neurosurgery ·(unknown), Thiam‐Chye Lim, Ning Chou, Swee Hin Teoh, Kim Cheng Tan, (unknown), Dietmar W. Hutmacher, Allan H. Friedman, William F. Chandler, Laligam N. Sekhar	1
17	Newer Anticonvulsants for Neurosurgery 2002 ·Contemporary Neurosurgery ·Parag G. Patil, Rodney A. Radtke, Allan H. Friedman	1
18	Newer Antimicrobials for Neurosurgery 2002 ·Contemporary Neurosurgery ·(unknown), Aimee K. Zaas, Daniel J. Sexton, Allan H. Friedman	3
19	Dorsal root entry zone lesions for intractable pain after trauma to the conus medullaris and cauda equina 1995 ·Journal of neurosurgery ·John H. Sampson, (unknown), Blaine S. Nashold, Allan H. Friedman	36
20	Nerve transposition for the restoration of elbow flexion following brachial plexus avulsion injuries 1990 ·Journal of neurosurgery ·Allan H. Friedman, James A. Nunley, Richard D. Goldner, W. Jerry Oakes, (unknown), James R. Urbaniak	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact